FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 113 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 469.50 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,344,000 | -45.5% | 292,742 | -54.0% | 0.00% | -40.0% |
| Q3 2019 | $2,466,000 | -63.6% | 636,552 | -43.3% | 0.01% | -61.5% |
| Q2 2019 | $6,766,000 | -12.2% | 1,122,242 | +95.2% | 0.01% | -56.7% |
| Q1 2019 | $7,704,000 | +126.1% | 574,920 | +56.9% | 0.03% | +100.0% |
| Q4 2018 | $3,407,000 | -10.0% | 366,377 | +66.2% | 0.02% | 0.0% |
| Q1 2018 | $3,787,000 | +30.0% | 220,413 | +65.9% | 0.02% | +36.4% |
| Q4 2017 | $2,912,000 | -46.5% | 132,865 | -0.1% | 0.01% | -52.2% |
| Q3 2017 | $5,441,000 | +876.8% | 133,003 | +763.7% | 0.02% | +666.7% |
| Q1 2017 | $557,000 | +27.8% | 15,400 | +77.0% | 0.00% | +50.0% |
| Q4 2016 | $436,000 | -82.9% | 8,700 | -82.1% | 0.00% | -81.8% |
| Q3 2016 | $2,551,000 | +12.6% | 48,600 | -11.3% | 0.01% | +10.0% |
| Q2 2016 | $2,266,000 | – | 54,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|